• Home

Cardiovascular Stents Market is Determined to Touch US$ 13,100.2 Mn and CAGR at 6.6% by 2025

Posted:

The increasing incidence of Cardiovascular Diseases worldwide is creating growth opportunities for the Global Cardiovascular Stents Market, predicts Fortune Business Insights in their new study. The study is titled “Cardiovascular Stents Market: Global Market Analysis, Insights and Forecasts, 2018 2025”. As per Fortune Business Insights, the market is prognosticated to exhibit 6.6% CAGR and reach a valuation of US$ 13,100.2 Mn by 2025 from US$ 7,838.9 Mn in 2017.

Browse Complete Report Details @

https://www.fortunebusinessinsights.com/industry-reports/cardiovascular-stents-market-100061

Key Segments Analysis:

By Product Type

  • Coronary Stenting
  • Peripheral Stenting

By Stent Type

  • Drug Eluting Stents (DES)
  • Bioresorbable Stents
  • Bare Metal Stents

By Disease Indication

  • Venous Disease
  • Arterial Disease

By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics
  • Catheterization Labs

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Get Sample PDF Brochure @

https://www.fortunebusinessinsights.com/enquiry/sample/cardiovascular-stents-market-100061

Increasing Number of Cardiovascular Cases to Fuel Demand in Market

Unhealthy lifestyle and irregular eating habits of people have led to having increased the prevalence of health-related concerns, including chronic diseases such as diabetes, obesity, and heart disorders. The surging cases of heart disorder are continuously fueling the demand for treating heart problems including angioplasty, which ultimately increased the demand for cardiovascular stents.

However, the market may face challenges due to the presence of alternative treatment methods for vascular diseases. Again, the complexity of cardiovascular stent implantation may cause patients to opt for other treatment options and this may restrict growth in the market. Besides this, the incident of product recalls and failures may also hamper the market in the future.

Some of the leading companies in the global Cardiovascular Stents Market are

  • Biotronik SE and Co. KG
  • Cardinal Health
  • Cook
  • R. Bard, Inc.
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • Braun Melsungen AG
  • Abbott
  • Boston Scientific Corporation
  • Medtronic

Alpine Stent to Open Growth Opportunities for Market in the Asia Pacific

The market for cardiovascular stents in the Asia Pacific is likely to show growth at a higher rate on account of the improved distribution of cardiovascular stents in emerging economies such as China and India. In order to improve their accessibility, price capping of stents is introduced in these developing nations and this will help the market gain momentum. Thus, Asia Pacific is likely to register itself as the fastest growing region in the during the forecast tenure.

The cardiovascular stents market in North America was emerged dominant and was valued at US$ 2,344.9 Mn in 2017. This is mainly due to the presence of better medical facilities and skilled professionals in the developed nations of Canada and the U.S. North America is likely to remain dominant in the coming years as well on account of ongoing clinical trials on novel stents in the U.S. and various regulatory approvals on cardiovascular stents.

Various companies operating in the global cardiovascular stents market are B. Braun Melsungen AG, Cardinal Health, C. R. Bard, Inc., Terumo Corporation, MicroPort Scientific Corporation, Biotronik SE and Co. KG, and others. Major vendors are focusing on investing in clinical studies and research and development of better stents. At present, Boston Scientific Corporation, Abbott, and Medtronic are leading the market.

Major Table of Content for Cardiovascular Stents Market:

7. Europe Cardiovascular Stents Market Analysis, Insights and Forecast, 2014-2025

7.1. Key Findings/ Summary

7.2. Market Analysis, Insights and Forecast By Procedure Type

7.2.1 Coronary Stenting

7.2.2 Peripheral Stenting

7.3. Market Analysis, Insights and Forecast By Stent Type

7.3.1 Drug Eluting Stents (DES)

7.3.2 Bioresorbable Stents

7.3.3 Bare Metal Stents

7.3.4 Others

7.4. Market Analysis, Insights and Forecast By Disease Indication

7.4.1 Venous Diseases

7.4.2 Arterial Diseases

7.5. Market Analysis, Insights and Forecast By End User

7.5.1 Hospitals

7.5.2 Ambulatory Surgery Centers

7.5.3 Specialty Clinics

7.5.4 Catheterization Labs

8. Asia Pacific Cardiovascular Stents Market Analysis, Insights and Forecast,2014-2025

8.1. Key Findings/ Summary

8.2. Market Analysis, Insights and Forecast By Procedure Type

8.2.1 Coronary Stenting

8.2.2Peripheral Stenting

8.3. Market Analysis, Insights and Forecast By Stent Type

8.3.1 Drug Eluting Stents (DES)

8.3.2 Bioresorbable Stents

8.3.3 Bare Metal Stents

8.3.4 Others

8.4. Market Analysis, Insights and Forecast By Disease Indication

8.4.1 Venous Diseases

8.4.2 Arterial Diseases

8.5. Market Analysis, Insights and Forecast By End User

8.5.1 Hospitals

8.5.2 Ambulatory Surgery Centers

8.5.3 Specialty Clinics

8.5.4 Catheterization Labs

8.6. Market Analysis, Insights and Forecast By Countries/Sub regions

8.6.1 China

8.6.2 India

8.6.3 Japan

8.6.4 Australia

8.6.5 Southeast Asia

8.6.6 Rest of Asia Pacific

9.Latin America Cardiovascular Stents Market Analysis, Insights and Forecast,2014-2025

9.1. Key Findings/ Summary

9.2. Market Analysis, Insights and Forecast By Procedure Type

9.2.1 Coronary Stenting

9.2.2 Peripheral Stenting

9.3. Market Analysis, Insights and Forecast By Stent Type

9.3.1 Drug Eluting Stents (DES)

9.3.2 Bioresorbable Stents

9.3.3 Bare Metal Stents

9.3.4 Others

.

10. Middle East and Africa Cardiovascular Stents Market Analysis, Insights and Forecast, 2014-2025

10.1. Key Findings/ Summary

10.2. Market Analysis, Insights and Forecast By Procedure Type

10.2.1 Coronary Stenting

10.2.2 Peripheral Stenting

10.3. Market Analysis, Insights and Forecast By Stent Type

10.3.1 Drug Eluting Stents (DES)

10.3.2 Bioresorbable Stents

10.3.3 Bare Metal Stents

10.3.4 Others

10.4. Market Analysis, Insights and Forecast By Disease Indication

10.4.1 Venous Diseases

10.4.2 Arterial Diseases

10.5. Market Analysis, Insights and Forecast By End User

10.5.1 Hospitals

10.5.2 Ambulatory Surgery Centers

10.5.3 Specialty Clinics

10.5.4 Catheterization Labs

10.6. Market Analysis, Insights and Forecast By Countries/Sub regions

10.6.1 GCC

10.6.2 South Africa

10.6.3 Rest of Middle East and Africa

11. Competitive Analysis

11.1. Key Industry Developments

11.2. Global Market Share Analysis (2017)

11.3. Competition Dashboard

11.4. Comparative Analysis Major Players

11.5. Company Profiles (Overview, Products and services, SWOT analysis, Recent developments, strategies, financials (based on availability))

11.5.1 Biotronik SE and Co. KG

11.5.2 Cardinal Health

11.5.3 Cook

11.5.4 C. R. Bard, Inc.

11.5.5 MicroPort Scientific Corporation

11.5.6 Terumo Corporation

11.5.7 B. Braun Melsungen AG

11.5.8 Abbott

11.5.9 Boston Scientific Corporation

11.5.10 Medtronic

11.5.11 Other Prominent Players

12.Strategic Recommendations

More Trending Topics from Fortune Business Insights:

Thrombin Market to be valued at US$ 738.7 Mn by 2025, Contributions from Baxter and Pfizer to drive Growth, says Fortune Business Insights

Retinal Disease Therapeutics Market to Reach US$ 21,318.0 Mn by 2026, Advancements in Retinal Disease Diagnosis Devices to Boost the Market, says Fortune Business Insights

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Cardiovascular Stents Market is Determined to Touch US$ 13,100.2 Mn and CAGR at 6.6% by 2025

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklymedia.com